Data backs Nevro spinal cord stimulation for diabetic neuropathy
Nevro (NYSE:NVRO) today announced 24-month data from its Senza painful diabetic neuropathy (PDN) spinal cord stimulation (SCS) trial.
Stay updated with breaking news from Item Index. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nevro (NYSE:NVRO) today announced 24-month data from its Senza painful diabetic neuropathy (PDN) spinal cord stimulation (SCS) trial.
Average Cost of Living in Pennsylvania: $49,040 per year On a cost of living level, Pennsylvania is about midway down. According to the 2022 MERIC cost of …
Average Cost of Living in Montana: $47,887 per year Take a good look at your monthly budget if you’re planning a move to Montana. According to MERIC data in 2022, …
Average Cost of Living in Maine: $50,559 per year Maine has the lowest cost of living in New England, beating out all five of its neighbors, …